A Phase 1, Open-Label Study to Evaluate the Effect of GDC-0810 on the Pharmacokinetics of Pravastatin in Healthy Female Subjects of Non-Childbearing Potential
Phase of Trial: Phase I
Latest Information Update: 18 Mar 2017
At a glance
- Drugs Brilanestrant (Primary) ; Pravastatin (Primary)
- Indications Breast cancer
- Focus Pharmacokinetics
- Sponsors Genentech
- 18 Mar 2017 Results presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
- 01 Mar 2016 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 01 Feb 2016 Planned end date changed from 1 Dec 2016 to 1 Feb 2016, as reported by ClinicalTrials.gov.